Tag: ZyCoV-D
Needle-free jet injection of novel COVID-19 DNA vaccine shows promise in animal model
In a recent study posted to the bioRxiv* server, researchers at the United States Army Medical Research Institute of Infectious Diseases evaluated the immunogenicity of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) deoxyribonucleic acid (DNA) vaccine, nCOV-S(JET), in rhesus macaques. A previous evaluation of this coronavirus disease 2019 (COVID-19)…
DCGI emergency use nod for Covaxin, Corbevax and ZyCoV-D across age groups
The Drug Controller General of India (DCGI) on Tuesday granted emergency use approvals to COVID-19 vaccines Covaxin, Corbevax and ZyCoV-D. While the emergency use authorisation (EUA) was granted to Bharat Biotech’s Covaxin for the age group of 6-12 years, Biological E’s Corbevax bagged the nod…
All you need to know about Covid-19 vaccines available for children
This news brings relief to every family in the country. Now, children above 5 years of age will also be given coronavirus vaccine in the entire country. Till now, children above the age of 12 years were getting the protection of the vaccine, but now children from 5 to 12…
Covaxin, Corbevax, ZyCoV-D Get DCGI Green Signal for Kids
In the wake of schools reporting a spike in coronavirus cases among children, the Drugs Controller General of India (DCGI) has approved the restricted emergency use of three vaccines for different age groups of children — Bharat Biotech’s Covaxin, Biological E’s Corbevax and Zydus Cadila’s ZyCov-D. Covaxin has received the…
What you need to know about the three vaccines approved for children by DCGI
Bharat Biotech COVAXIN – approved for children aged 6-12 years – is made by inactivating the coronavirus – a shot that contains dead parts of SARS-CoV2. Photo : iStock KEY HIGHLIGHTS Biological E’s Cobervax – approved for children aged 5-12 years – is made from a part of the coronavirus,…
3 months after arrival in Bihar, not a single Covid vaccine shot given
New Delhi: Close to three months since the arrival of the first consignment of ZyCoV-D in Bihar, the vaccine is yet to be included in the nationwide immunisation drive against Covid-19. Data available on the CoWIN dashboard shows that the four vaccines currently part of the vaccination programme are Covaxin,…
Sensex climbs 236 pts; breadth remains weak
The benchmark indices firmed up further in early afternoon trade. The Nifty regained the 16,500 mark. Realty shares extended recent losses. At 12:20 IST, the barometer index, the S&P BSE Sensex, surged 236.29 points or 0.43% at 55,565.61. The Nifty 50 index added 53.30 points or 0.32% at…
